These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 26563652

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Isolation of a human anti-epidermal growth factor receptor Fab antibody, EG-19-11, with subnanomolar affinity from naïve immunoglobulin repertoires using a hierarchical antibody library system.
    Hur BU, Yoon JB, Liu LK, Cha SH.
    Immunol Lett; 2010 Nov 30; 134(1):55-61. PubMed ID: 20797408
    [Abstract] [Full Text] [Related]

  • 25. Affinity maturation of antiHER2 monoclonal antibody MIL5 using an epitope-specific synthetic phage library by computational design.
    Qiao C, Lv M, Li X, Geng J, Li Y, Zhang J, Lin Z, Feng J, Shen B.
    J Biomol Struct Dyn; 2013 Nov 30; 31(5):511-21. PubMed ID: 23003339
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Phage display and hybridoma generation of antibodies to human CXCR2 yields antibodies with distinct mechanisms and epitopes.
    Rossant CJ, Carroll D, Huang L, Elvin J, Neal F, Walker E, Benschop JJ, Kim EE, Barry ST, Vaughan TJ.
    MAbs; 2014 Nov 30; 6(6):1425-38. PubMed ID: 25484064
    [Abstract] [Full Text] [Related]

  • 28. A novel anti-human HB-EGF monoclonal antibody with multiple antitumor mechanisms against ovarian cancer cells.
    Miyamoto S, Iwamoto R, Furuya A, Takahashi K, Sasaki Y, Ando H, Yotsumoto F, Yoneda T, Hamaoka M, Yagi H, Murakami T, Hori S, Shitara K, Mekada E.
    Clin Cancer Res; 2011 Nov 01; 17(21):6733-41. PubMed ID: 21918176
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Inhibition of transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasiveness.
    Gaspar NJ, Li L, Kapoun AM, Medicherla S, Reddy M, Li G, O'Young G, Quon D, Henson M, Damm DL, Muiru GT, Murphy A, Higgins LS, Chakravarty S, Wong DH.
    Mol Pharmacol; 2007 Jul 01; 72(1):152-61. PubMed ID: 17400764
    [Abstract] [Full Text] [Related]

  • 31. Characterization of a high-affinity human antibody with a disulfide bridge in the third complementarity-determining region of the heavy chain.
    Almagro JC, Raghunathan G, Beil E, Janecki DJ, Chen Q, Dinh T, LaCombe A, Connor J, Ware M, Kim PH, Swanson RV, Fransson J.
    J Mol Recognit; 2012 Mar 01; 25(3):125-35. PubMed ID: 22407976
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Molecular basis of in vitro affinity maturation and functional evolution of a neutralizing anti-human GM-CSF antibody.
    Eylenstein R, Weinfurtner D, Härtle S, Strohner R, Böttcher J, Augustin M, Ostendorp R, Steidl S.
    MAbs; 2016 Mar 01; 8(1):176-86. PubMed ID: 26406987
    [Abstract] [Full Text] [Related]

  • 34. Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent.
    Beiboer SH, Reurs A, Roovers RC, Arends JW, Whitelegg NR, Rees AR, Hoogenboom HR.
    J Mol Biol; 2000 Feb 25; 296(3):833-49. PubMed ID: 10677285
    [Abstract] [Full Text] [Related]

  • 35. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
    Chen Y, Wiesmann C, Fuh G, Li B, Christinger HW, McKay P, de Vos AM, Lowman HB.
    J Mol Biol; 1999 Nov 05; 293(4):865-81. PubMed ID: 10543973
    [Abstract] [Full Text] [Related]

  • 36. TGFβ2 and TGFβ3 isoforms drive fibrotic disease pathogenesis.
    Sun T, Huang Z, Liang WC, Yin J, Lin WY, Wu J, Vernes JM, Lutman J, Caplazi P, Jeet S, Wong T, Wong M, DePianto DJ, Morshead KB, Sun KH, Modrusan Z, Vander Heiden JA, Abbas AR, Zhang H, Xu M, N'Diaye EN, Roose-Girma M, Wolters PJ, Yadav R, Sukumaran S, Ghilardi N, Corpuz R, Emson C, Meng YG, Ramalingam TR, Lupardus P, Brightbill HD, Seshasayee D, Wu Y, Arron JR.
    Sci Transl Med; 2021 Aug 04; 13(605):. PubMed ID: 34349032
    [Abstract] [Full Text] [Related]

  • 37. Combined inhibition of IL1, CXCR1/2, and TGFβ signaling pathways modulates in-vivo resistance to anti-VEGF treatment.
    Carbone C, Tamburrino A, Piro G, Boschi F, Cataldo I, Zanotto M, Mina MM, Zanini S, Sbarbati A, Scarpa A, Tortora G, Melisi D.
    Anticancer Drugs; 2016 Jan 04; 27(1):29-40. PubMed ID: 26473526
    [Abstract] [Full Text] [Related]

  • 38. Discovering neutralizing antibodies targeting the stem epitope of H1N1 influenza hemagglutinin with synthetic phage-displayed antibody libraries.
    Tung CP, Chen IC, Yu CM, Peng HP, Jian JW, Ma SH, Lee YC, Jan JT, Yang AS.
    Sci Rep; 2015 Oct 12; 5():15053. PubMed ID: 26456860
    [Abstract] [Full Text] [Related]

  • 39. A novel rabbit anti-hepatocyte growth factor monoclonal neutralizing antibody inhibits tumor growth in prostate cancer cells and mouse xenografts.
    Yu Y, Chen Y, Ding G, Wang M, Wu H, Xu L, Rui X, Zhang Z.
    Biochem Biophys Res Commun; 2015 Aug 14; 464(1):154-60. PubMed ID: 26093299
    [Abstract] [Full Text] [Related]

  • 40. Isolation and affinity maturation of hapten-specific antibodies.
    Sheedy C, MacKenzie CR, Hall JC.
    Biotechnol Adv; 2007 Aug 14; 25(4):333-52. PubMed ID: 17383141
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.